CellPictureRollingBasicLayer

Virtual Symposium 2020

Registration is now open for the our 9th Annual Symposium. This year it will take place virtually on Wednesday 21st October 2020.

Register now

slider-1-back

About the Centre

Harnessing world leading science to cure cancer

Find out more about us
bokeh-slider-background

Research

We have achieved a critical mass of investment here in Oxford and the opportunities for cancer research are immense

Find out more...

funding-slider-background

Funding

The Centre supports researchers at every stage of their career and are committed to facilitating more excellent science in Oxford

Learn about our funding

Become part of the Cancer Research UK Oxford Centre Community

Become a Member

Latest news 

Helping blood cancer patients in the COVID era

The Oxford-led UK Coronavirus Cancer Monitoring Project was launched earlier this year to help clinicians better treat blood cancer patients in a safe way during the COVID-pandemic

Tackling blood cancers in Tanzania and Uganda

Scientists from Tanzania, Uganda and Oxford University have teamed up in a new child blood cancer program

Previously unknown ‘genetic vulnerability’ in breast cancer found

New Nature paper reveals discovery of a genetic vulnerability in nearly 10% of breast cancer tumours and how this can be targeted to selectively kill cancer cells.

Balancing the benefits and risks of radiotherapy for Hodgkin lymphoma

Dr Rebecca Shakir is devising a tool to allow some blood cancer patients to make more informed decisions about the risks and benefits of their radiotherapy treatment

Epigenetic markers for melanoma patient response to ICB therapy

Development fund winners Rosalin Cooper & Ben Fairfax are investigating the epigenetic landscape of melanoma patients and how it can impact patient sensitivity to ICB therapy

Harnessing immune cell therapy in cancer

Prof Paresh Vyas and his team are investigating how to harness the power of T cells as therapies for patients with a range of blood cancers

New melanoma cancer drug in development shows promise

University of Oxford and Immunocore Ltd have investigated Tebentafusp, a new anti-tumor immune response drug for patients with metastatic melanoma

The relationship between iRhom2 and KRAS proteins

Development Fund winners from the Freeman group are investigating newly discovered proteins and their potential as targets for new cancer treatments

The impact of COVID-19 on cancer patients

A new study from the UK Coronavirus Cancer Monitoring Project (UKCCMP) has investigated which cancer patients may be more susceptible to the impacts of coronavirus

Twitter

Development fund

Funding

The Centre supports researchers at every stage of their career and are committed to facilitating more excellent science in Oxford.

Learn more
Resources

Research

We have achieved a critical mass of investment here in Oxford and the opportunities for cancer research are immense.

Learn more
DPhil

Graduate studies

Oxford is consistently ranked the world’s best for clinical, pre-clinical, and health training. It is within this rich environment that the Centre implements its strategy for training the next generation of cancer researchers.

Learn more
OCRC symposium

Events

Through our networking and events programme, the Centre brings together the individual components of the Centre into a cohesive community for cancer research.

Learn more

Oxford Centre Films

Participating in an early phase clinical trial (Part 1) – being recruited to a trial

Participating in an early phase clinical trial (Part 2) – during the trial

CRUK Oxford Centre International Symposium on Oesophageal Cancer

Get in touch

Got a Question? Want to learn more about the Centre? Please contact us!

You can also find the centre and get direction using our location page.

Contact us